KAREN GIMBLET: Open Payments
NPI 1396997607 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 22 payments from 13 companies in 2025. Trend: 2023 $188 · 2024 $311 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| ABBVIE INC. | 5 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Exact Sciences Corporation | 2 | $29 |
| TOLMAR, INC. | 1 | $21 |
| Abbott Laboratories | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: FARXIGA, VRAYLAR, XIFAXAN, Cologuard Collection Kit, QULIPTA, JATENZO, FREESTYLE LIBRE 3, BREZTRI.
Industry payments across NC — which companies pay providers there.
